Keep pulling the thread on Bessent Visits Japan.
Japanese authorities are attempting to prevent the yen from weakening past an unofficial line of 160 yen per U.S. dollar.
Japan has conducted a few suspected currency interventions in the past week by selling U.S. treasuries to buy yen.
A rate hike from the Bank of Japan is expected at its June meeting.
The market expects the year-over-year Consumer Price Index (CPI) for the U.S. to be 3.7% for the month of April.
The market expects the U.S. core Consumer Price Index (CPI) to increase to 2.7% in April from 2.6% in the prior month.
The U.S. Personal Consumption Expenditures (PCE) price index, which is the Federal Reserve's preferred inflation gauge, was 3.2% year-over-year as of a few weeks ago.
The market expects the U.S. headline Producer Price Index (PPI) to increase to 4.8% in April from 4.0% in March.
The market expects the U.S. retail sales control group number to decline to 0.4% in April from 0.7% in the prior month.
Hims & Hers Health has a partnership with Novo Nordisk to sell the weight-loss drug Wegovy on its telehealth platform.
JP Morgan initiated coverage on Hims & Hers Health with an overweight rating, citing the company's deal with Novo Nordisk.
Options markets are pricing a potential 13% move in the share price of Hims & Hers Health following its upcoming earnings report.
UBS raised its price target on Applied Materials to $480 from $430.